STOCK TITAN

Orchestra BioMed: RTW reports 16.2% ownership

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13D/A

Rhea-AI Filing Summary

Orchestra BioMed Holdings, Inc. (OBIO) is the issuer whose common stock the RTW Funds purchased: 1,200,000 shares from underwriters of its public offering on November 9, 2026, at $5.00 per share. The purchase was funded with the RTW Funds’ working capital.

RTW Investments, LP, investment advisor to the RTW Funds, and Roderick Wong, M.D., its managing partner and chief investment officer, each reported beneficial ownership of 13,142,394 shares, or 16.2%, with shared voting and dispositive power. The percentage is based on 78,704,957 shares outstanding as of November 9, 2026, giving effect to Pre-Funded Warrants held by the RTW Funds.

Shares purchased 1,200,000 shares Purchased by the RTW Funds on November 9, 2026
Purchase price $5.00 per share Price paid by the RTW Funds
Beneficial ownership 13,142,394 shares Reported by each of RTW Investments, LP and Roderick Wong, M.D.
Ownership percentage 16.2% Based on 78,704,957 shares outstanding as of November 9, 2026, giving effect to Pre-Funded Warrants held by the RTW Funds
Shares outstanding 78,704,957 shares As of November 9, 2026, giving effect to Pre-Funded Warrants held by the RTW Funds
beneficially owned regulatory
"aggregate amount beneficially owned by each reporting person"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
Shared Voting Power regulatory
"Shared Voting Power 13,142,394.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
Shared Dispositive Power regulatory
"Shared Dispositive Power 13,142,394.00"
Pre-Funded Warrants financial
"giving effect to Pre-Funded Warrants held by the RTW Funds"
Pre-funded warrants are financial instruments that give investors the right to purchase a company's stock at a set price, but with most or all of the purchase price paid upfront. They function like a coupon or gift card for stock, allowing investors to buy shares later at a fixed price, which can be beneficial if they want to avoid future price increases. This makes them important for investors seeking flexibility and certainty in their investment plans.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many OBIO shares did the RTW Funds buy, and at what price?

The RTW Funds purchased 1,200,000 shares at $5.00 per share on November 9, 2026, from underwriters of Orchestra BioMed Holdings’ public offering.

How many OBIO shares did RTW Investments and Roderick Wong beneficially own?

RTW Investments, LP and Roderick Wong, M.D., each reported beneficial ownership of 13,142,394 shares, or 16.2%, with shared voting and dispositive power. The percentage was based on 78,704,957 shares outstanding as of November 9, 2026, giving effect to Pre-Funded Warrants held by the RTW Funds.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





68572M106

(CUSIP Number)
Roderick Wong, M.D.
RTW Investments, LP, 40 10th Avenue, Floor 7
New York, NY, 10014
(646) 597-6980

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
11/09/2026

(Date of Event Which Requires Filing of This Statement)


If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).




schemaVersion:


SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D


RTW Investments, LP
Signature:/s/ Roderick Wong, M.D.
Name/Title:Roderick Wong, M.D., Managing Partner
Date:11/12/2026
Roderick Wong
Signature:/s/ Roderick Wong, M.D.
Name/Title:Roderick Wong, M.D.
Date:11/12/2026

Keep reading